ADC THERAPEUTICS
Live / Applied — Examiner's amendment mailed (as of 25 Mar 2026)
What this means for you
Not registered yet, but its 10 Nov 2025 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 99489063
- Mark type
- Stylized text
- Filed
- 10 Nov 2025
- Attorney of record
- Tracy-Gene G. Durkin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in the prevention of cancer and tumors; pharmaceutical preparations for use in the prevention and treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations for human use, namely, immunotherapies for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and biological preparations in the nature of pharmaceutical and biological preparations for the treatment of infectious, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; gene therapy products in the nature of pharmaceutical and biological preparations for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; pharmaceutical preparations and substances for conditioning patients to receive therapies for the treatment of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic preparations for medical purposes; diagnostic biomarker reagents for medical purposes; diagnostic agents, preparations, and substances for medical purposes; reagents for medical use; diagnostic kits comprised of medical diagnostic reagents and assays to test tissue for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; diagnostic kits comprised of medical diagnostic reagents and assays to test bodily fluids for use in the detection of infectious, oncological, inflammatory, immune, auto-immune, genetic, and rare diseases, disorders, and conditions; medical diagnostic assays for testing body fluids; medical diagnostic assays for testing body tissue; diagnostic kits comprised of medical diagnostic assays to test for cell expressions for use in identifying pharmaceutical preparations and therapies for treating medical diseases, disorders, and conditions in humans
Owner
- ADC Therapeutics SA, Epalinges, CH
Prior registrations
Prosecution history
- 25 Mar 2026 — EXAMINER'S AMENDMENT ENTERED
- 25 Mar 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 25 Mar 2026 — EXAMINERS AMENDMENT E-MAILED
- 25 Mar 2026 — EXAMINERS AMENDMENT -WRITTEN
- 20 Mar 2026 — ASSIGNED TO EXAMINER
- 10 Nov 2025 — APPLICATION FILING RECEIPT MAILED
- 10 Nov 2025 — NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
- 10 Nov 2025 — NEW APPLICATION ENTERED